Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma

Leukemia and Lymphoma

Volumn 45, Issue 5, 2004, Pages 951-955

  Cohen, Amos M ^a,c   Grinblat, Borislava ^b   Bessler, Hanna ^a   Kristt, Donald A ^a   Kremer, Alona ^b   Shalom, Sarah ^b   Schwartz, Ariel ^a   Halperin, Marisa ^a   Merkel, Drorit ^a   Don, Jeremy ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

B CLL; Gene expression; Human Pim 2; Non Hodgkin's lymphoma

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; PROTEIN HPIM 2; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE ACTIVATION; CANCER GROWTH; CANCER LOCALIZATION; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LEUKEMOGENESIS; LYMPHOCYTE ACTIVATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; UPREGULATION;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPH NODES; LYMPHOMA, NON-HODGKIN; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; UP-REGULATION;

EID: 11144354804     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001641251     Document Type: Article

References (17)

1. Van der Lugt, N.M.T., Domen, J., Verhoeven, E., Linders, K., Van der Gulden, H., Allen, J. and Berns, A. (1995) "PRoviral tagging in Eμ-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2", EMBO Journal, 14, 2536-2544.
2. Berns, A., Mikkers, H., Krimpenfort, P., Allen, J., Scheijen, B. and Jonkers, J. (1999) "IDentification and characterization of collaborating oncogenes in compound mutant mice", Cancer Research, 59, 1773s-1777s.
3. Chen, X.P., Losman, J.A., Cowan, S., Donahue, E., Fay, S., Vuong, B.Q., et al. (2002) "PIm serine/threonine kinases regulate the stability of Socs-1 protein", Proceedings of the National Academy Sciences of the United States of America, 99, 2175-2180.
4. Baytel, D., Shalom, S., Madgar, I., Weissenberg, R. and Don, J. (1998) "THe human Pim-2 proto-oncogene and its testicular expression". Biochimica et Biophysica Acta, 1442, 274-285.
5. Shirogane, T., Fukada, T., Muller, J.M., Shima, D.T., Hibi, M. and Hirano, T. (1999) "SYnergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis", Immunity, 11, 709-719.
6. Li, J., Peet, G.W., Balzarano, D., Li, X., Massa, P., Barton, R.W. and Marcu, K.B. (2001) "NOvel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition", Journal of Biological Chemistry, 276, 18579-18590.
7. Nieborowska-Skorska, M., Hoser, G., Kossev, P., Wasik, M.A. and Skorski, T. (2002) "COmplementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis", Blood, 99, 4531-4539.
8. Xu, L.G., Wu, M., Hu, J., Zhai, Z. and Shu, H.B. (2002) "IDentification of downstream genes up-regulated by tumor necrosis factor family member TALL-1", Journal Leukocyte Biology, 72, 410-416.
9. Mikovits, J., Ruscetti, F., Zhu, W., Bagni, R., Dorjsuren, D. and Shoemaker, R. (2001) "POtential cellular signatures of viral infections in human hematopoietic cells", Disease Markers, 17, 173-178.
10. Claudio, J.O., Masih-Khan, E., Tang, H., Goncalves, J., Voralia, M., Li, Z.H., et al. (2002) "A molecular compendium of genes expressed in multiple myeloma", Blood, 100, 2175-2186.
11. Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., et al. (1981) "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis", Cancer, 48, 198-206.
12. Müller-Hermelnik, H.K., Montserrat, E., Catovsky, D. and Harris, N.L. (2001) Chronic lymphocytic leukemia/small lymphocytic lymphoma. In Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, edited by E.S. Jaffe, N.L. Harris, H. Stein and J.W. Vardiman. Pp. 127-130. Lyon: IARC Press.
13. Gatter, K.C. and Warnke, R.A. (2001) Diffuse large B-cell lymphoma. In Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, edited by E.S. Jaffe, N.L. Harris, H. Stein and J.W. Vardiman. Pp. 171-174. Lyon: IARC Press.
14. Wang, Z., Bhattacharya, N., Meyer, M.K., Seimiya, H., Tsuruo, T., Tonani, J.A. and Magnuson, N.S. (2001) "PIm-1 negatively regulates the activity of PTP-U2S phosphatase and influences terminal differentiation and apoptosis of monoblastoid leukemia cells". Archives of Biochemistry and Biophysics, 390, 9-18.
15. Fox, C.J., Hammerman, P.S., Cinalli, R.M., Master, S.R., Chodosh, L.A. and Thompson, C.B. (2003) "THe serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor", Genes and Development, 17, 1841-1854.
16. Furman, R.R., Asgary, Z., Mascarenhas, J.O., Liou, H.C. and Schattner, E.J. (2000) "MOdulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells", Journal of Immunology, 164, 2200-2206.
17. Yan, B., Zemskova, M., Holder, S., Chin, V., Kraft, A., Koskinen, P.J. and Lilly, M. (2003) "THe PIM-2 kinase phosphorylates BAD on serine-112 and reverses BAD induced cell death"+ Journal of Biological Chemistry, 278, 45358-45367.